Impact of pre-ICU balanced crystalloids versus saline on mortality in sepsis: a propensity score-matched multicenter cohort study.

Authors

Tae Wan Kim, Yumi Kim, Moon Seong Baek, Gyungah Kim, Ryoung-Eun Ko, Gee Young Suh, Chae-Man Lim, Nakyung Jeon, Won-Young Kim, Korean Sepsis Alliance (KSA) Investigators

Published in

Chest. Sep 19, 2026. Epub Sep 19, 2026.

Abstract

The optimal crystalloids for initial fluid resuscitation in sepsis remain uncertain. Most previous studies have focused on intensive care unit (ICU), leaving the pre-ICU admission impact of crystalloid type unclear.
Is there an association between pre-ICU admission crystalloid type administration and clinical outcomes in patients with sepsis?
This nationwide multicenter retrospective cohort study analyzed adult patients with sepsis between September 2019 and December 2023. Patients receiving initial fluid resuscitation before ICU admission were categorized into balanced crystalloid or 0.9% sodium chloride (saline) groups. The primary outcome was 30-day mortality.
Among 3,688 patients (mean [standard deviation] age 71.9 [13.8] years; 58% male), 1,381 (37.4%) received balanced crystalloids and 2,307 (62.6%) received saline before ICU admission. After propensity score matching, 1,335 patients remained in each group. Balanced crystalloid use was associated with lower 30-day mortality, resulting in an adjusted odds ratio (aOR) of 0.69 (95% confidence interval [CI] 0.56-0.83). The finding was consistent after inverse probability of treatment weighting (aOR, 0.78; 95% CI 0.69-0.88). The association between balanced crystalloids and mortality was consistent across age, sex, disease severity, liberal fluid management (pre-ICU fluid volume >30 mL/kg), and pre-ICU vasopressor use. Notably, mortality risk was lower with balanced crystalloids in patients without chronic kidney disease, received fluids in the emergency department or ward (vs. operating room or other ICU), with baseline chloride ≤110 mmol/L, and baseline pH <7.35. Further, balanced crystalloid use was associated with reduced need for continuous renal replacement therapy during ICU stay, reduced renal replacement therapy at ICU discharge, and increased 28-day ventilator-free days.
Pre-ICU administered balanced crystalloid use was associated with lower 30-day mortality in patients with sepsis than saline.

PMID:
42762986
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.